New Delhi, April 18 -- United States President Donald Trump on Saturday ordered his administration to accelerate the review process for certain psychedelic substances, including Ibogaine. The drug has recently gained support from combat veterans and some conservative lawmakers, despite being associated with significant safety concerns.

Ibogaine and other psychedelics are currently classified under the federal government's strictest category for illegal, high-risk substances. However, the administration is moving to relax some restrictions and encourage research into their potential medical uses, particularly for conditions such as severe depression.

Ibogaine was originally used in spiritual practices by followers of the Bwiti religion i...